352 related articles for article (PubMed ID: 10398670)
1. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.
Doniger J; Muralidhar S; Rosenthal LJ
Clin Microbiol Rev; 1999 Jul; 12(3):367-82. PubMed ID: 10398670
[TBL] [Abstract][Full Text] [Related]
2. Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53.
Kashanchi F; Araujo J; Doniger J; Muralidhar S; Hoch R; Khleif S; Mendelson E; Thompson J; Azumi N; Brady JN; Luppi M; Torelli G; Rosenthal LJ
Oncogene; 1997 Jan; 14(3):359-67. PubMed ID: 9018122
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
[TBL] [Abstract][Full Text] [Related]
4. A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation.
Thompson J; Doniger J; Rosenthal LJ
Arch Virol; 1994; 136(1-2):161-72. PubMed ID: 8002783
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions.
Nicholas J; Martin ME
J Virol; 1994 Feb; 68(2):597-610. PubMed ID: 8289364
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.
Bonin LR; McDougall JK
J Virol; 1997 Aug; 71(8):5861-70. PubMed ID: 9223475
[TBL] [Abstract][Full Text] [Related]
7. The human cytomegalovirus IE2 86 kDa protein elevates p53 levels and transactivates the p53 promoter in human fibroblasts.
Muganda P; Carrasco R; Qian Q
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):321-31. PubMed ID: 9593583
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription.
Muralidhar S; Doniger J; Mendelson E; Araujo JC; Kashanchi F; Azumi N; Brady JN; Rosenthal LJ
J Virol; 1996 Dec; 70(12):8691-700. PubMed ID: 8970996
[TBL] [Abstract][Full Text] [Related]
9. Mapping and DNA sequence analysis of the cytomegalovirus transforming domain III (mtrIII).
Wang J; Razzaque A
Virus Res; 1993 Dec; 30(3):221-38. PubMed ID: 8109157
[TBL] [Abstract][Full Text] [Related]
10. Identification of two promoters within human cytomegalovirus morphologic transforming region II.
Inamdar A; Thompson J; Kashanchi F; Doniger J; Brady JN; Rosenthal LJ
Intervirology; 1992; 34(3):146-53. PubMed ID: 1338782
[TBL] [Abstract][Full Text] [Related]
11. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
12. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells.
Wu J; O'Neill J; Barbosa MS
J Virol; 1998 Jan; 72(1):236-44. PubMed ID: 9420220
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.
Hagemeier C; Caswell R; Hayhurst G; Sinclair J; Kouzarides T
EMBO J; 1994 Jun; 13(12):2897-903. PubMed ID: 8026474
[TBL] [Abstract][Full Text] [Related]
15. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
16. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells.
Murphy EA; Streblow DN; Nelson JA; Stinski MF
J Virol; 2000 Aug; 74(15):7108-18. PubMed ID: 10888651
[TBL] [Abstract][Full Text] [Related]
17. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function.
Wing BA; Johnson RA; Huang ES
J Virol; 1998 Mar; 72(3):1814-25. PubMed ID: 9499032
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes.
Marchini A; Liu H; Zhu H
J Virol; 2001 Feb; 75(4):1870-8. PubMed ID: 11160686
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus product UL44 downregulates the transactivation of HIV-1 long terminal repeat.
Boccuni MC; Campanini F; Battista MC; Bergamini G; Dal Monte P; Ripalti A; Landini MP
AIDS; 1998 Mar; 12(4):365-72. PubMed ID: 9520165
[TBL] [Abstract][Full Text] [Related]
20. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein.
Choi KS; Kim SJ; Kim S
Virology; 1995 Apr; 208(2):450-6. PubMed ID: 7747417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
